spravato ketamine - Search News

Johnson & Johnson's Spravato nasal spray okayed

Hosted on MSN · 2d

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

Can a Nasal Spray Really Help Treat Depression? Here's What to Know About Spravato

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Popular Science · 3d

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

1d

Does Medicare cover ketamine infusions for mental health conditions?

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

US Weekly on MSN9d

What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, More

Celebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...

Hosted on MSN1d

FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with it

On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results